Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities:
Net loss	$ (81,949)	$ (105,980)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	8,912	9,229
Stock-based compensation expense	7,993	7,692
Inventory impairments and abandonments	148,618	618
Deferred and other income tax (benefit) expense	(44,758)	112,752
Gain on sale of fixed assets	(142)	(207)
Change in allowance for doubtful accounts	(20)	62
Equity in income of unconsolidated entities	(315)	(329)
Cash distributions of income from unconsolidated entities	409	331
Non-cash (gain) loss on extinguishment of debt	(574)	3,173
Changes in operating assets and liabilities:
Decrease in accounts receivable	4,380	8,256
(Increase) in income tax receivable	0	(31)
(Increase) in inventory	(156,472)	(222,304)
(Increase) in other assets	(776)	(3,469)
Increase in trade accounts payable	26,009	39,651
(Decrease) increase in other liabilities	(5,520)	17,080
Net cash used in operating activities	(94,205)	(133,476)
Cash flows from investing activities:
Capital expenditures	(16,365)	(13,894)
Proceeds from sale of fixed assets	162	226
Acquisition, net of cash acquired	(4,088)	0
Investments in unconsolidated entities	0	(421)
Return of capital from unconsolidated entities	0	176
Net cash used in investing activities	(20,291)	(13,913)
Cash flows from financing activities:
Repayment of debt	(22,333)	(401,509)
Proceeds from issuance of new debt	0	400,000
Repayment of borrowings from credit facility	(235,000)	(75,000)
Borrowings from credit facility	340,000	75,000
Debt issuance costs	(400)	(5,743)
Repurchase of common stock	(34,624)	0
Tax payments for stock-based compensation awards	(1,889)	(1,565)
Stock option exercises	278	62
Net cash provided by (used in) financing activities	46,032	(8,755)
Decrease in cash, cash equivalents, and restricted cash	(68,464)	(156,144)
Cash, cash equivalents, and restricted cash at beginning of period	153,248	304,609
Cash, cash equivalents, and restricted cash at end of period	$ 84,784	$ 148,465